Astellas Pharma: Pipeline , Products ,Performance ,Potential
Publisher Name » Espicom
Published Date » 2010-01-31
No. Of Pages » 146
Table of Contents
EXECUTIVE SUMMARY
A detailed and comprehensive overview of current financial position, company strategy, product and pipeline analysis.
THERAPEUTIC AREA FOCUS
Key product analysis and forecasting
Cardiovascular
Adenoscan (adenosine)
Lexiscan (regadenoson)
Lipitor (atorvastatin)
Micardis (telmisartan)
Inflammation & Immunology
Celecox (celecoxib)
Prograf (tacrolimus)
Urology
Harnal/Omnic/Flomax (tamsulosin)
Vesicare (solifenacin)
Infectious Disease
Funguard/Mycamine (micafungin)
Geninax (garenoxacin)
Gastrointestinal
Gaster/Pepcid (famotidine)
Central Nervous System
Myslee (zolpidem)
Seroquel (quetiapine)
Dermatology
Protopic (tacrolimus)
Oncology
Eligard (leuprolide)
OPERATIONAL DATA
A wealth of background and detail
A full 5-year financial performance assessment
Key corporate events
Key agreements
Infrastructure
Subsidiaries and joint ventures
List of Tables
NAList of Figures
NAUpcoming Reports:
|
Software Defined Networking (SDN) Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
Software defined networking (SDN) refers to a network infrastructure where network control plane is decoupled from physical topology. The software defined networking market is growing in demand as it is offering a number of advantages like increased flexibility, improved performance, and simplified operations among others.
The software defined networking industry is growing as one of the most promising industries as it is providing network operators with better control over network infrastructure, thus allowing optimization and modification, and reduction in overall cost. With...
|
|
Renewable Chemicals - Global Industry Analysis, Market Share, Size, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Renewable chemicals are used for enhancing the use of renewable resources rather than fossil fuels. Renewable chemicals include all the chemicals which are produced from renewable feedstock such as microorganisms, biomass (plant, animal, and marine), and agricultural raw materials. Strict government regulations, environmental concerns and awareness among people are enhancing the use of bio-based products produced from biomass sources, which in turn is expanding the market for renewable chemicals.
The renewable chemicals market is expanding primarily due to the strict...
|
|
Commercial Satellite Imaging Market - Global Industry Size, Market Share, Trends Analysis, And Forecast, 2012 - 2018
By - Transparency Market Research
Commercial satellite imaging is the process of gathering data in the form of images through the use of a satellite. The commercial satellite imaging market is on a rise because of incorporation of imaging websites such as Google Earth.
The commercial satellite imaging market could be segmented into two major categories: on the basis of types into: earth or terrestrial imaging, aeronautical imaging and satellite imaging, and on the basis of end users into: geospatial imaging industry, commercial enterprises, civil engineering industry and others. The market could also be...
|
Research Assistance
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Email: sales@researchmoz.com
Select License type:
Latest Reports
- The Future of the Wine Market in Indonesia to 2017
- The Future of the Wine Market in Hungary to 2017
- The Future of the Wine Market in Hong Kong to 2017
- The Future of the Wine Market in Greece to 2017
- The Future of the Wine Market in Finland to 2017
- The Future of the Wine Market in Egypt to 2017
- The Future of the Wine Market in Denmark to 2017
- The Future of the Wine Market in Czech Republic to 2017
- The Future of the Wine Market in the United Kingdom to 2017
- Switzerland Quarterly Beverage Tracker Report Q1 2013
Related News
|
One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
|
|
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples.
The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
|
|
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
|
|
Battling against flu, vaccination necessary for health workers
Sep 14, 2012
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease.
Health officials...
|
|
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...
|

